Pregmune
Pregmune is a reproductive health technology company specializing in AI-powered reproductive immunology assessments to identify overlooked causes of infertility, miscarriages, and IVF failures. Their flagship product, IRMA, uses decades of clinical data and machine learning to provide personalized treatment guidance in collaboration with patients' own physicians. Pregmune's business model involves direct patient payments for assessments and coordination with independent laboratories for testing. The company is led by a team of physicians, clinicians, researchers, and data scientists dedicated to improving fertility outcomes through advanced diagnostics and expert treatment recommendations.
Pregmune
Pregmune is a reproductive health technology company specializing in AI-powered reproductive immunology assessments to identify overlooked causes of infertility, miscarriages, and IVF failures. Their flagship product, IRMA, uses decades of clinical data and machine learning to provide personalized treatment guidance in collaboration with patients' own physicians. Pregmune's business model involves direct patient payments for assessments and coordination with independent laboratories for testing. The company is led by a team of physicians, clinicians, researchers, and data scientists dedicated to improving fertility outcomes through advanced diagnostics and expert treatment recommendations.
TL;DR
Company: Pregmune
Headquarters: Newton, Massachusetts, United States
Core product: IRMA — AI-powered reproductive immunology assessment
Focus: Diagnosing immunological causes of infertility, recurrent pregnancy loss, and failed IVF
Employee count (reported): 8
Known funding: Seed (~$150k, May 2021)
Company Overview
Problem Domain
Reproductive immunology diagnostics for infertility, recurrent pregnancy loss, and failed IVF cycles.
Industry
Reproductive health / Diagnostics
Funding Track Record
$152,000
Reported May 2021 seed round (Dealroom / company funding entries)